Cardlytics Inc (NAS:CDLX)
$ 3.65 +0.090 (+2.53%) Market Cap: 21.49 Mil Enterprise Value: 183.34 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 32/100

Q1 2025 Cardlytics Inc Earnings Call Transcript

May 7, 2025 / 09:00 PM GMT
Release Date Price: $21.6 (+0.47%)

Key Points

Positve
  • Cardlytics Inc (CDLX) reported strong consumer spending data, with growth in categories like auto, home improvement, e-commerce, and apparel.
  • The company successfully launched with a new large financial institution (FI) partner, which is now one of their top five banks in terms of billing's run rate.
  • Cardlytics Inc (CDLX) expanded its network beyond financial institutions by signing its first non-FI partner agreement with a leading digital sports platform.
  • The company has improved its tech stack, allowing for quicker onboarding of new partners, reducing integration time significantly.
  • Cardlytics Inc (CDLX) introduced new metrics, Monthly Qualified Users (MQUs) and Adjusted Contribution per MQU (ACPU), to better reflect their business performance.
Negative
  • Total billings decreased by 7.3% year-over-year, and revenue decreased by 8.4%, driven by lower top-line billings and a category mix of advertisers.
  • The travel category saw a decline due to shrinking budgets from key accounts.
  • Adjusted EBITDA was negative $4.4 million, a decline of $4.6 million compared to the previous year.
  • The company announced a 15% reduction in its workforce to manage costs, which may impact employee morale and productivity.
  • There is ongoing macroeconomic uncertainty, leading advertisers to be cautious with their budgets, impacting Cardlytics Inc (CDLX)'s revenue potential.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CDLX.OQ - Cardlytics Inc
Q1 2025 Cardlytics Inc Earnings Call
May 07, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, Thank you for standing by and welcome to the Cariolytics in 1 2025 earnings conference call. At this time, all participants line are in a listen-only mode. Following the presentation, we will conduct a question and answer session.

If you wish to ask a question during that time, please press star and 1 on your telephone keypad. If at any time during the call you require immediate assistance, please press 0 for the operator.

This call is being recorded on Wednesday, May 7, 2025.

Now I would like to turn the call over to Nick Linton, Chief Legal and Privacy officer. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot